Juvit D3 (Colecalciferol)

Juvit D3 (colecalciferol) is employed in the vitamin D pathway to address disorders of calcium metabolism.

• Vitamin D deficiency: restores adequate serum 25‑hydroxyvitamin D levels to support normal bone mineralization.
• Osteoporosis prevention: helps maintain bone density and reduces fracture risk in at‑risk adults.
• Rickets prevention: supplies essential vitamin D for proper bone growth in children.

• Colecalciferol is converted in the liver to 25‑hydroxyvitamin D, which is further hydroxylated in the kidney to the active hormone 1,25‑dihydroxyvitamin D (calcitriol). Calcitriol binds to intracellular vitamin D receptors, forming a complex that regulates gene transcription, enhancing intestinal absorption of calcium and phosphate and promoting bone mineralization. It also modulates immune function and influences cell proliferation, supporting skeletal health and calcium homeostasis.

Oral colecalciferol is generally well tolerated, but some individuals may experience adverse reactions.

Common Side Effects

• Nausea: mild stomach upset after ingestion.
• Constipation: occasional difficulty passing stools.
• Dry mouth: sensation of reduced salivation.
• Fatigue: transient feeling of tiredness.
• Headache: mild cranial discomfort.

Serious or Rare Side Effects

• Hypercalcemia: elevated blood calcium causing weakness, confusion, or cardiac arrhythmia.
• Kidney stones: formation of calcium‑based calculi in the urinary tract.
• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Calcification of soft tissues: abnormal calcium deposits in organs.
• Persistent vomiting: may indicate toxicity.

Before using Juvit D3, consider the following precautions to ensure safe and effective therapy.

• Assess baseline vitamin D status: measure serum 25‑hydroxyvitamin D levels to guide supplementation.
• Monitor calcium levels: avoid hypercalcemia in patients with disorders of calcium metabolism.
• Use caution in renal impairment: adjust dose or monitor closely in chronic kidney disease.
• Avoid concurrent high‑dose calcium or vitamin A supplements: may increase risk of toxicity.
• Pregnancy and lactation: consult healthcare provider as safety data are limited.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Colecalciferol can interact with several medicines, altering its effectiveness or increasing risk of adverse events.

Major Interactions (Avoid)

• Thiazide diuretics: may potentiate hypercalcemia.
• High‑dose calcium supplements: increase risk of calcium overload.
• Vitamin A excess: combined toxicity leading to hypercalcemia.
• Digoxin: elevated calcium may enhance digoxin toxicity.
• Antacids containing aluminum or magnesium: reduce absorption of vitamin D.

Moderate Interactions (Monitor Closely)

• Glucocorticoids: may decrease vitamin D activation, requiring dose adjustment.
• Antiepileptic drugs (phenytoin, carbamazepine): increase vitamin D metabolism, lowering levels.
• Orlistat: may reduce absorption of fat‑soluble vitamins.
• Bariatric surgery patients: altered absorption may necessitate monitoring.
• Cholestyramine: can bind vitamin D and reduce its bioavailability.